Related Experiment Videos
Cell-mediated immune responses in chronic liver diseases
British Medical Journal
|February 26, 1972
Summary
The leucocyte migration test identified abnormal cell-mediated immune responses in patients with active chronic hepatitis, primary biliary cirrhosis, and drug-induced jaundice. Treatments like prednisone improved these responses, suggesting a role in disease perpetuation and multisystem involvement.
Area of Science:
- Immunology
- Hepatology
- Cellular Immunology
Background:
- Cell-mediated immunity plays a role in various liver disorders.
- The leucocyte migration test can assess cellular immune responses to specific antigens.
Purpose of the Study:
- To investigate cell-mediated immune responses to liver antigens in patients with diverse liver conditions.
- To evaluate the impact of immunosuppressive therapy on these immune responses.
Main Methods:
- Leucocyte migration test performed on 163 patients with various liver disorders.
- Assessment of responses to liver, salivary gland, and kidney antigens.
- Correlation of immune responses with clinical diagnosis and treatment status.
Main Results:
- Abnormal leucocyte migration was most frequent in primary biliary cirrhosis (64%) and active chronic hepatitis (53%).
- Abnormal responses were also noted in drug hypersensitivity jaundice and in cases with multisystem involvement (Sjögren's syndrome, renal tubular acidosis).
- Patients with active chronic hepatitis on immunosuppressive therapy (prednisone, azathioprine) showed more normal test results and improvement during treatment.
Conclusions:
- Cell-mediated immune responses are implicated in the pathogenesis and perpetuation of chronic liver diseases.
- Cross-reactivity with antigens in other organs may explain multisystem involvement in some liver conditions.
- Immunosuppressive therapy may modulate these aberrant immune responses, potentially aiding disease management.